Very important to note that Nigel released this before being approached by the ASX, just to cover for ML. Nigel is on the ball!!! Looks like we have a new chairman!
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%